pharmaphorum’s digital magazine Deep Dive is published online six times a year and reaches a global audience of highly engaged pharmaceutical and biotechnology decision-makers.

Each Deep Dive issue combines a focus topic – either sales and marketing, digital, market access, oncology, patients or R&D – with an additional mixture of thought-provoking content and commercial opportunities include:

• Features (interview style article, up to 2,000 words)
• Features (client-written article, up to 2,000 words)
• 12 questions with...
• Case studies
• Company profiles
• Digital advertising
• Edition sponsorship
• Bespoke editions

The Deep Dive team can offer full editorial support in planning and writing articles, including the inclusion of appropriate graphics and links. Articles receive a one-month cycle of promotion and a digital and print PDF versions of articles are provided after the issue is published.

Previous companies that have benefitted from this included: Alexion, AstraZeneca, Beigene, Daiichi Sankyo, EVERSANA, Frontiers Health, Healthware, Lumanity, M3, NIHR, Phesi, PurpleLeaf Strategy, Real Chemistry, Research Partnership, Syneos Health, and Viseven.

Upcoming Deep Dive issues for 2025 will include:

June 2025: Oncology

Deep Dive digital magazine

With oncology at the cutting edge of medical innovation, this edition explores the critical intersection of science, policy, and equity. Dive into:

  • Highlights from ASCO 2025
  • Advances in biomarker-driven therapies and companion diagnostics.
  • Will cell and gene therapies remain exclusive to a few, or is broader access possible?
  • Are liquid biopsies ready for mainstream adoption in early cancer detection?

 

September 2025: AI

As artificial intelligence reshapes every stage of the drug lifecycle, the challenge is no longer whether AI can drive innovation, but how to measure its true impact. This edition explores: 

  • How to benchmark for speed and accuracy improvement over human-led drug discovery. 
  • Can AI predict pricing and reimbursement challenges before they happen? 
  • AI’s impact on drug safety monitoring and adverse event detection.

  • How AI is being used to track long-term therapy 

     

October 2025: Patients & Partnerships

As patient expectations shift and technology transforms engagement, pharma’s role in partnerships is evolving. This issue examines:

  • How patient activation strategies are evolving in an increasingly digital landscape.
  • How pharma can use data partnerships to improve access and adherence.
  • Co-creating clinical trial designs with patient organisations.

  • Personalised patient pathways: How tech is enabling tailored support solutions.

     

November 2025: Equity & Sustainability

As the pharma industry navigates the balance between innovation, access, and environmental responsibility, new strategies are emerging to drive sustainable impact. This edition looks at:

  • Insights and updates from Frontiers Health 2025 
  • The role of tiered pricing and alternative payment models in improving affordability.
  • Tackling drug waste and optimising sustainable supply chains.
  • The industry’s responsibility in preparing for the next pandemic.

  • The intersection of climate change and infectious disease threats.

     

Let us help you connect with your clients, email advertising@pharmaphorum.com or download our media pack for more information about Deep Dive and our other offerings.